Fierce Pharma

FEBRUARY 27, 2024

A seismic shift has occurred in the healthcare landscape. Delivering on these heightened expectations has fueled the urgency to invest in patient engagement and support.

Biopharma 170

Biopharma Patients Healthcare Healthcare 170

Fierce Pharma

OCTOBER 3, 2024

Matthew Walsh, General Manager of Biopharma at ixlayer - the leading cloud-based platform powering an end-to-end, direct-to-patient healthcare solution - sat down with Fierce at Digital Phar | Matthew Walsh, General Manager of Biopharma at Ixlayer – a cloud-based platform specialist empowering operational efficiency, patient access, and improved outcomes (..)

Patients 130

Patients Biopharma Management Pharma 130

MedCity News

DECEMBER 27, 2022

When diversity is well-implemented in healthcare materials, trust is built and patient-provider relationships improve. It also enhances the medical accuracy of the information presented.

Patients 244

Patients Healthcare Healthcare Medical 244

MedCity News

AUGUST 27, 2023

We can apply this approach in pharma by enhancing our patient journey maps and go beyond focusing on the key clinical engagement touch points (e.g., doctor visits, prescription pickups) and enriching our insights with the micro-moments surrounding these obvious events.

Healthcare 242

Healthcare Healthcare Prescription Doctors 242

Fierce Pharma

SEPTEMBER 19, 2023

Artificial intelligence (AI) has enormous potential in healthcare, but all too often, it gets misunderstood. With the right infrastructure, intelligent tools stand to not only process data but also improve clinical decision-making—helping find more patients for biopharma companies, and faster, too.

Biopharma 207

Biopharma Healthcare Healthcare Patients 207

MedCity News

SEPTEMBER 15, 2024

To realize true, sustainable savings in total cost of care, the healthcare system needs to reconsider the support — or lack of support — it provides throughout patients’ medication experiences and the snowball effect that creates on a lifetime of healthcare costs.

Medical 295

Medical Healthcare Healthcare Patients 295

MedCity News

OCTOBER 23, 2024

For patients who may be unable to afford the high cost of GLP-1 obesity drugs or are worried about the side effects, it’s important for healthcare providers to offer education on herbal alternatives and consider these as part of the broader treatment conversation. appeared first on MedCity News.

Side effects 304

Side effects Healthcare Provider Education Healthcare 304

MedCity News

JANUARY 5, 2023

The adoption of eCOA technology in mental healthcare research can make pivotal advancements in mental health patient care. Electronic Clinical Outcomes Assessment and digital health tools were well-suited to accommodate the rapid rise of virtual and telehealth shifts during the Covid-19 pandemic and there is no going back.

Electronics 317

Electronics Healthcare Healthcare Patients 317

MedCity News

OCTOBER 3, 2024

The Hippocratic oath can’t stop with direct patient care; the healthcare industry and its key stakeholders must address persistent public health problems systematically. We have the tools to reduce medication harm by half or more; it is long past time to make this a public health priority.

Medical 321

Medical Healthcare Healthcare Patients 321

pharmaphorum

DECEMBER 18, 2022

Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. We believe that innovation in patient access models is the necessary catalyst to aid patients in starting on and staying on the therapies they need to improve their lives.

Biopharma 98

Biopharma Patients Prescription Medical 98

MedCity News

MAY 14, 2023

There is a huge opportunity for PBMs and health systems to use AI to help address the challenges surrounding the affordability and accessibility of medicines, from navigating formularies to resolving prior authorization. More automation in pharmacies and with ordering workflows is one piece of that puzzle.

Medical 349

Medical Patients Medicine Biopharma 349

MedCity News

SEPTEMBER 11, 2022

The pandemic showed that the healthcare system can respond and evolve when confronted by an existential threat. It’s time to fundamentally improve the cancer journey, while ensuring that resources are used more wisely.

Patients 245

Patients Healthcare Healthcare Biopharma 245

MedCity News

SEPTEMBER 21, 2023

This article explores the benefits of implementing RFID in healthcare settings and how hospitals can gradually transition from barcode to RFID-enabled medication systems, leading to substantial cost savings and improved patient care.

Medical 279

Medical Healthcare Healthcare Leads 279

MedCity News

JUNE 16, 2023

Investors in 2022 appeared confident that the continued transformation of drug research and development protocols and the overall life sciences industry will not only include digital health solutions, but will even depend on them for data collection, analysis, patient engagement, and even their therapeutic properties.

Pharma 311

Pharma Food and Drug Administration Recruitment Patients 311

MedCity News

JUNE 4, 2024

By working together to build an ecosystem of support around people with diabetes, the healthcare system as a whole can ensure that no one slips through the cracks. The post As Interest in GLP-1s Explodes, People Living With Diabetes Need Structured Support To Ensure Effective Use appeared first on MedCity News.

Healthcare 305

Healthcare Healthcare Biopharma Patients 305

MedCity News

NOVEMBER 7, 2023

I knew the healthcare system in this country was overwhelmed so I quickly learned the importance of being an informed advocate for my own care. There was a drug already approved for metastatic patients that was now being tested on patients like me–survivors of early-stage breast cancer–in an effort to prevent a recurrence.

Doctors 317

Doctors Patients Leads Marketing 317

MedCity News

DECEMBER 27, 2023

While it may appear that hospital administrators and biotech CEOs have quite dissimilar jobs because they face different challenges daily, this article attempts to conveys the value of some of the underlying principles that one can develop in the field of hospital administration, that may have some value in other healthcare fields and in other executive (..)

Healthcare 289

Healthcare Healthcare Biopharma Patients 289

MedCity News

JUNE 12, 2023

One of the fastest-growing frontiers of healthcare is Digital Therapeutics (DTx), which utilizes clinically tested software to prevent, treat, and manage a growing range of medical conditions. The goal was simple: provide access and focused support to patients remotely while simultaneously relieving overtaxed healthcare facilities.

Food and Drug Administration 263

Food and Drug Administration Prescription Government FDA 263

European Pharmaceutical Review

NOVEMBER 12, 2024

Overall, the biopharma firm explained that these initial US investments are part of AstraZeneca’s plan to attain $80 billion in Total Revenue by the end of the decade. The expansion is set to strengthen AstraZeneca’s capability to manufacture biologic medicines for patients worldwide.

Manufacturing 59

Manufacturing Biopharma Healthcare Healthcare 59

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?

Patients 98

Patients Healthcare Healthcare Marketing 98

Clarivate

JUNE 29, 2023

OpenAI’s launch of ChatGPT on March 14 heralds a new era of artificial intelligence that will have profound implications for society, including the life science and healthcare industries. Our customers entrust our products and services to help them improve patient health, and we will not jeopardize that mission.

Patients 98

Patients Safety Healthcare Healthcare 98

PM360

AUGUST 9, 2022

Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. Innovation Is Expanding, But Healthcare Systems Are Slow to Adapt. Driving scale in a slow-moving healthcare ecosystem is not just a challenge for cell and gene therapies.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

PM360

FEBRUARY 1, 2024

Embarking on the journey from product development to market success in the biopharma industry is no small feat. According to a McKinsey report , a startling 40% of biopharma products fail to meet their sales forecasts within the initial two years, prompting a critical reassessment of strategies for product launches.

Biopharma 59

Biopharma Competition Prescription Marketing 59

World of DTC Marketing

JUNE 8, 2021

They are going to allow Biogen NINE years for follow-up clinical trials in which time our healthcare system is going to pay a TON of money for hope. There are no efficacy data to clearly demonstrate this drug helps patients. Over that 9 years, Biogen can squeeze patients and payers for their $56,000 price. Nowhere to be seen.

FDA 207

FDA Food and Drug Administration Patients Biopharma 207

Pharmaceutical Technology

JUNE 24, 2022

invoX Pharma has signed a definitive agreement for the acquisition of all issued and outstanding shares of clinical-stage biopharma firm F-star Therapeutics, in a deal valued at nearly $161m or $7.12 The post invoX Pharma agrees to acquire biopharma firm F-star Therapeutics for $161m appeared first on Pharmaceutical Technology.

Biopharma 64

Biopharma Pharma Pharmacology Healthcare 64

Clarivate

MARCH 8, 2023

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. Biopharma companies are investing in the use of real world data (RWD) to accelerate innovation. The treatment of patients experiencing acute disease is quite dynamic.

Patients 59

Patients Biopharma Medical science Electronics 59

PM360

APRIL 22, 2024

This is especially relevant in biopharmaceutical patient engagement, where regulatory infractions can have existential consequences. The Unique Challenges of Patient/Pharma Interaction Patient engagement has become a critical component of medical marketing.

Patients 52

Patients Biopharma Ethics Marketing 52

European Pharmaceutical Review

NOVEMBER 18, 2022

The product, produced by biopharma company PTC Therapeutics, is approved for patients 18 months and over. It has been granted marketing authorisation by the Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain. Upstaza clinical trials.

Side effects 126

Side effects Biopharma Safety Marketing 126

Clarivate

APRIL 24, 2023

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. billion deal to acquire Oak Street Health, a value-based primary-care company focused on treating Medicare patients.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Clarivate

AUGUST 17, 2022

In our latest podcast, Ideas to Innovation, we speak with Dr. Grace Lomax, the clinical director at Patient Connect, part of Clarivate. Grace tells us about her experience as a physician and discusses healthcare literacy and education at the point of care. Supporting patients at the point of care. Dr. Grace Lomax.

Healthcare 52

Healthcare Healthcare Patients Physicians 52

PM360

JUNE 24, 2024

But the role of AI in healthcare will go beyond this. healthcare, with its 17% share of GDP, is “the most disruptable industry in the world,” and “the first big carcass that AI is going to start to feed on.” Patients can look forward to electronic assistance that can return their voice or other lost abilities.

Healthcare 52

Healthcare Healthcare Patients Side effects 52

PM360

MAY 21, 2024

From connecting with patients by interactive ads to dabbling into cross-platform integration, here is what our specialists had to say. What are new and effective ways of engaging patients who are now using streaming services? Biopharma marketers are following their audiences and investment in this channel continues to increase.

Media 105

Media Healthcare Healthcare Marketing 105

Pharmaceutical Technology

APRIL 20, 2023

CBC CEO Fu Wei stated: “Hasten is a well-established Chinese biopharma company with tremendous growth potential. Hasten will also use the proceeds from the round to fund future acquisitions. The firm reported 47% growth in sales from Q2 to Q4 in 2022, which is testament to CBC’s unique and effective investor-operator strategy.

Biopharma 98

Biopharma Healthcare Healthcare Sales 98

European Pharmaceutical Review

JANUARY 8, 2024

The European Commission (EC) has now granted a marketing authorisation for biopharma company UCB’s treatment, as an add-on to standard therapy in patients who have this rare autoimmune condition. It is indicated as a subcutaneous, add-on to standard therapy in these patients.

Biopharma 98

Biopharma Medicine Healthcare Healthcare 98

PharmExec

AUGUST 9, 2023

Biopharma has a responsibility to meet patients where they are.

Biopharma 52

Biopharma Healthcare Healthcare Patients 52

PM360

JUNE 30, 2022

Now, the two companies will unite their full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services to create a new organization called Inizio. It includes companies Vynamic, Research Partnership, Putnam Associates, and STEM Healthcare.

Specialization 97

Specialization Medical Healthcare Healthcare 97

Impetus Digital

JANUARY 26, 2023

Ittai Dayan , Co-founder & CEO of Rhino Health , shared how his company is transforming the way healthcare AI solutions are created, adopted and measured. For example, taking a patient registry, you work on re-structured data and then add to that, imaging data. If you enjoyed this episode, kindly leave a review on iTunes.

Healthcare 52

Healthcare Healthcare Professional Services Electronics 52